Generating a Prion with Bacterially Expressed Recombinant Prion Protein

Overview

Journal Science

Specialty Science

Date 2010 Jan 30

PMID 20110469

Citations 393

Authors

Fei Wang

Xinhe Wang

Chong-Gang Yuan

Jiyan Ma

Affiliations

Soon will be listed here.

Abstract

The prion hypothesis posits that a misfolded form of prion protein (PrP) is responsible for the infectivity of prion disease. Using recombinant murine PrP purified from Escherichia coli, we created a recombinant prion with the attributes of the pathogenic PrP isoform: aggregated, protease-resistant, and self-perpetuating. After intracerebral injection of the recombinant prion, wild-type mice developed neurological signs in approximately 130 days and reached the terminal stage of disease in approximately 150 days. Characterization of diseased mice revealed classic neuropathology of prion disease, the presence of protease-resistant PrP, and the capability of serially transmitting the disease; these findings confirmed that the mice succumbed to prion disease. Thus, as postulated by the prion hypothesis, the infectivity in mammalian prion disease results from an altered conformation of PrP.

Citing Articles

Cofactors facilitate bona fide prion misfolding in vitro but are not necessary for the infectivity of recombinant murine prions.

Perez-Castro M, Perez-Castro M, Erana H, Vidal E, Charco J, Lorenzo N PLoS Pathog. 2025; 21(1):e1012890.

PMID: 39841704 PMC: 11774496. DOI: 10.1371/journal.ppat.1012890.

Excitatory neuron-prone prion propagation and excitatory neuronal loss in prion-infected mice.

Erdenebat T, Komatsu Y, Uwamori N, Tanaka M, Hoshika T, Yamasaki T Front Mol Neurosci. 2024; 17:1498142.

PMID: 39726739 PMC: 11669680. DOI: 10.3389/fnmol.2024.1498142.

Rapid and sensitive determination of residual prion infectivity from prion-decontaminated surfaces.

Simmons S, Payne V, Hrdlicka J, Taylor J, Larsen P, Wolf T mSphere. 2024; 9(9):e0050424.

PMID: 39189773 PMC: 11423590. DOI: 10.1128/msphere.00504-24.

Neuropathologically directed profiling of PRNP somatic and germline variants in sporadic human prion disease.

McDonough G, Cheng Y, Morillo K, Doan R, Zhou Z, Kenny C Acta Neuropathol. 2024; 148(1):10.

PMID: 39048735 PMC: 11328154. DOI: 10.1007/s00401-024-02774-2.

Neuropathologically-directed profiling of somatic and germline variants in sporadic human prion disease.

McDonough G, Cheng Y, Morillo K, Doan R, Kenny C, Foutz A bioRxiv. 2024; .

PMID: 38979287 PMC: 11230391. DOI: 10.1101/2024.06.25.600668.

References

Kocisko D, Come J, Priola S, Chesebro B, Raymond G, Lansbury P . Cell-free formation of protease-resistant prion protein. Nature. 1994; 370(6489):471-4. DOI: 10.1038/370471a0. View

Castilla J, Saa P, Hetz C, Soto C . In vitro generation of infectious scrapie prions. Cell. 2005; 121(2):195-206. DOI: 10.1016/j.cell.2005.02.011. View

Caughey B, Baron G . Prions and their partners in crime. Nature. 2006; 443(7113):803-10. DOI: 10.1038/nature05294. View

Telling G, Parchi P, DeArmond S, Cortelli P, Montagna P, Gabizon R . Evidence for the conformation of the pathologic isoform of the prion protein enciphering and propagating prion diversity. Science. 1996; 274(5295):2079-82. DOI: 10.1126/science.274.5295.2079. View

Tamguney G, Giles K, Glidden D, Lessard P, Wille H, Tremblay P . Genes contributing to prion pathogenesis. J Gen Virol. 2008; 89(Pt 7):1777-1788. PMC: 2828448. DOI: 10.1099/vir.0.2008/001255-0. View

Raeber A, Sailer A, Hegyi I, Klein M, Rulicke T, Fischer M . Ectopic expression of prion protein (PrP) in T lymphocytes or hepatocytes of PrP knockout mice is insufficient to sustain prion replication. Proc Natl Acad Sci U S A. 1999; 96(7):3987-92. PMC: 22407. DOI: 10.1073/pnas.96.7.3987. View

Wang F, Yang F, Hu Y, Wang X, Wang X, Jin C . Lipid interaction converts prion protein to a PrPSc-like proteinase K-resistant conformation under physiological conditions. Biochemistry. 2007; 46(23):7045-53. DOI: 10.1021/bi700299h. View

Baron G, Magalhaes A, Prado M, Caughey B . Mouse-adapted scrapie infection of SN56 cells: greater efficiency with microsome-associated versus purified PrP-res. J Virol. 2006; 80(5):2106-17. PMC: 1395383. DOI: 10.1128/JVI.80.5.2106-2117.2006. View

Bueler H, Aguzzi A, Sailer A, Greiner R, Autenried P, Aguet M . Mice devoid of PrP are resistant to scrapie. Cell. 1993; 73(7):1339-47. DOI: 10.1016/0092-8674(93)90360-3. View

10.

Geoghegan J, Valdes P, Orem N, Deleault N, Williamson R, Harris B . Selective incorporation of polyanionic molecules into hamster prions. J Biol Chem. 2007; 282(50):36341-53. PMC: 3091164. DOI: 10.1074/jbc.M704447200. View

11.

Caughey B, Baron G, Chesebro B, Jeffrey M . Getting a grip on prions: oligomers, amyloids, and pathological membrane interactions. Annu Rev Biochem. 2009; 78:177-204. PMC: 2794486. DOI: 10.1146/annurev.biochem.78.082907.145410. View

12.

Legname G, Baskakov I, Nguyen H, Riesner D, Cohen F, DeArmond S . Synthetic mammalian prions. Science. 2004; 305(5684):673-6. DOI: 10.1126/science.1100195. View

13.

Manuelidis L . A 25 nm virion is the likely cause of transmissible spongiform encephalopathies. J Cell Biochem. 2006; 100(4):897-915. DOI: 10.1002/jcb.21090. View

14.

Aguzzi A, Baumann F, Bremer J . The prion's elusive reason for being. Annu Rev Neurosci. 2008; 31:439-77. DOI: 10.1146/annurev.neuro.31.060407.125620. View

15.

Bessen R, Kocisko D, Raymond G, Nandan S, Lansbury P, Caughey B . Non-genetic propagation of strain-specific properties of scrapie prion protein. Nature. 1995; 375(6533):698-700. DOI: 10.1038/375698a0. View

16.

Castilla J, Morales R, Saa P, Barria M, Gambetti P, Soto C . Cell-free propagation of prion strains. EMBO J. 2008; 27(19):2557-66. PMC: 2567411. DOI: 10.1038/emboj.2008.181. View

17.

Gabizon R, McKinley M, Prusiner S . Purified prion proteins and scrapie infectivity copartition into liposomes. Proc Natl Acad Sci U S A. 1987; 84(12):4017-21. PMC: 305012. DOI: 10.1073/pnas.84.12.4017. View

18.

Collinge J, Clarke A . A general model of prion strains and their pathogenicity. Science. 2007; 318(5852):930-6. DOI: 10.1126/science.1138718. View

19.

Deleault N, Geoghegan J, Nishina K, Kascsak R, Williamson R, Supattapone S . Protease-resistant prion protein amplification reconstituted with partially purified substrates and synthetic polyanions. J Biol Chem. 2005; 280(29):26873-9. DOI: 10.1074/jbc.M503973200. View

20.

Pan T, Chang B, Wong P, Li C, Li R, Kang S . An aggregation-specific enzyme-linked immunosorbent assay: detection of conformational differences between recombinant PrP protein dimers and PrP(Sc) aggregates. J Virol. 2005; 79(19):12355-64. PMC: 1211538. DOI: 10.1128/JVI.79.19.12355-12364.2005. View